Oral Paracetamol versus Oral Ibuprofen in the Management of Patent Ductus Arteriosus in Preterm Infants: A Randomized Controlled Trial
- 1 March 2014
- journal article
- research article
- Published by Elsevier BV in The Journal of Pediatrics
- Vol. 164 (3), 510-514.e1
- https://doi.org/10.1016/j.jpeds.2013.11.008
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Intravenous Paracetamol for Patent Ductus Arteriosus in Premature Infants - A Lower Dose Is Also EffectiveNeonatology, 2013
- Intravenous Paracetamol Treatment in the Management of Patent Ductus Arteriosus in Extremely Low Birth Weight InfantsNeonatology, 2012
- An alternative drug (paracetamol) in the management of patent ductus arteriosus in ibuprofen-resistant or contraindicated preterm infantsArchives of Disease in Childhood: Fetal & Neonatal, 2012
- Ductal Closure With Paracetamol: A Surprising New Approach to Patent Ductus Arteriosus TreatmentPEDIATRICS, 2011
- Efficacy and Safety of Oral Versus Intravenous Ibuprofen in Very Low Birth Weight Preterm Infants with Patent Ductus ArteriosusThe Journal of Pediatrics, 2011
- Does Ibuprofen Increase Neonatal Hyperbilirubinemia?PEDIATRICS, 2009
- Randomized Pilot Study Comparing Oral Ibuprofen With Intravenous Ibuprofen in Very Low Birth Weight Infants With Patent Ductus ArteriosusPEDIATRICS, 2008
- The Ductus Arteriosus Rarely Requires Treatment in Infants > 1000 GramsAmerican Journal of Perinatology, 2008
- Oral-ibuprofen-induced acute renal failure in a preterm infantPediatric Nephrology, 2008
- Cellular mechanisms of acetaminophen: role of cyclo‐oxygenaseThe FASEB Journal, 2005